Human Recombinant NAP-2 (from E. coli)
Anbieter: Shenandoah Biotechnology
New Product
Zertifikate
Über diesen Artikel
Neutrophil activating peptide 2 (NAP-2), also known as CXCL7, is a member of the CXC family of chemokines. NAP-2 is a carboxyl-terminal fragment produced by proteolytic cleavage of the platelet basic protein (PBP). NAP-2 is released from platelets and binds to the receptors CXCR1 and CXCR2 to chemoattract and activate neutrophils during inflammatory events.
- High quality
- Low endotoxin
- Affordable
Caution: For research use only.
Technische Daten
- Konjugation:Unconjugated
- Protein-Funktion:Cytokine
- Protein/Peptid-Typ:Rekombinant
- Ursprung:E. coli
- Spezies:Human
- Lagerbedingungen:–20 °C
- Endotoxingehalt:Endotoxin LAL (EU/µg) ≤0,1
- Biologische Aktivität:Bioactivity: No biological activity data is available at this time
- Gen-ID:P02775
- Reconstitution instructions:Sterile water at 0,1 mg/ml
- Frei von Endotoxinen:N
- Frei von Trägern:Y
- Frei von Proteasen:N
- Tierfrei:N
- Proteinsynonym:Platelet basic protein|MDGF|LDGF|PBP|CXCL7, Neutrophil activating peptide 2|PPBP
- Protein/Peptid-Name:NAP-2
- Purity:≥95%
- Molecular weight:7,6 kDa
- Sequence:AELRCMCIKT TSGIHPKNIQ SLEVIGKGTH CNQVEVIATL KDGRKICLDP DAPRIKKIVQ KKLAGDESAD
- Endotoxinspiegel:Low
- Zusammensetzung:10 mM Sodium phosphate, pH 7,5
- Frei von Nukleasen:N
- Sorte:RUO
- Transporttemperatur:RT
Technische Daten
Frequently Bought Together